跳至主要内容
临床试验/NCT05011539
NCT05011539已完成不适用

Thiol-disulfide Homeostasis in Patients With Ovarian Cancer

Tepecik Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2021年4月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
115
试验地点
1
主要终点
thiol - disulfide levels

研究概览

简要总结

Ovarian cancer is the third most common after endometrial and cervical cancer in societies with a high standard of living; It is the second most common type of gynecological cancer after cervical cancer in societies with a low standard of living, and it is also the deadliest among gynecological cancers. Dynamic thiol-disulfide homeostasis is an antioxidant system that minimizes oxidative damage and prevents cell damage. In the presence of oxidative stress, the thiol groups combine to form the disulfide structure, and when the oxidative stress condition is over, they are separated into thiol groups again. This homeostasis is impaired in conditions that cause oxidative processes such as diabetes, cardiovascular diseases, cancers, rheumatoid arthritis, and chronic kidney failure. This can be determined by measuring the total thiol and native thiol levels. Likewise, the level of ischemia modified albumin increases in the case of oxidative stress. There are studies on this homeostasis in the literature on many types of cancer; There are studies on endometrial cancer and cervical cancer, which are gynecological cancers In this study, the usability of these tests together with other diagnostic tests in the diagnosis of ovarian cancer will be evaluated.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Histopathological diagnosis of ovarian cancer

排除标准

  • Having an acute or chronic disease that will cause oxidative stress
  • Using alcohol/cigarettes/drugs
  • Using antioxidant agents (such as vitamins A, C, E)

结局指标

主要结局

thiol - disulfide levels

时间窗: April 2021 - January 2022

the rate of total thiol, native thiol and total oxidant/antioxidant capacity

次要结局

未报告次要终点

研究者

发起方
Tepecik Training and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alaattin Karabulut

Medical Doctor

Tepecik Training and Research Hospital

研究点 (1)

Loading locations...

相似试验